Hang Xu Selected Research

Phosphofructokinase-2 (Phosphofructokinase 2)

1/2021	Adipocyte inducible 6-phosphofructo-2-kinase suppresses adipose tissue inflammation and promotes macrophage anti-inflammatory activation.
6/2012	Targeted overexpression of inducible 6-phosphofructo-2-kinase in adipose tissue increases fat deposition but protects against diet-induced insulin resistance and inflammatory responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hang Xu Research Topics

Disease

35	Neoplasms (Cancer) 05/2022 - 08/2010
12	Carcinoma (Carcinomatosis) 05/2022 - 01/2018
11	Inflammation (Inflammations) 01/2021 - 06/2012
10	Prostatic Neoplasms (Prostate Cancer) 02/2022 - 01/2019
9	Schizophrenia (Dementia Praecox) 10/2021 - 01/2020
8	Insulin Resistance 01/2021 - 01/2012
7	Obesity 03/2021 - 01/2014
5	Carcinogenesis 08/2022 - 03/2019
5	Urinary Bladder Neoplasms (Bladder Cancer) 05/2022 - 01/2021
5	Ischemic Stroke 01/2020 - 01/2017
4	Hemorrhage 01/2022 - 12/2019
4	Stroke (Strokes) 01/2022 - 12/2017
4	Cognitive Dysfunction 01/2021 - 01/2018
4	Mental Disorders (Mental Disorder) 01/2021 - 08/2015
4	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2012
4	Brain Ischemia (Cerebral Ischemia) 12/2019 - 02/2011
4	Reperfusion Injury 12/2019 - 02/2011
3	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2018
3	Hypoxia (Hypoxemia) 01/2022 - 03/2021
3	Renal Cell Carcinoma (Grawitz Tumor) 11/2021 - 01/2021
3	Body Weight (Weight, Body) 04/2021 - 08/2015
3	Diarrhea 01/2021 - 01/2019
3	Hyperplasia 01/2020 - 04/2013
3	Infarction (Infarctions) 12/2018 - 02/2011
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 04/2021
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 03/2019
2	Neuroinflammatory Diseases 10/2021 - 12/2018
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 10/2021 - 01/2020
2	Breast Neoplasms (Breast Cancer) 05/2021 - 01/2017
2	Wounds and Injuries (Trauma) 01/2021 - 01/2019
2	Neurobehavioral Manifestations 01/2021 - 01/2020
2	Sepsis (Septicemia) 01/2021 - 01/2019
2	COVID-19 01/2021 - 12/2020
2	Fibrosis (Cirrhosis) 10/2020 - 01/2019
2	Thrombosis (Thrombus) 01/2020 - 04/2013
2	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2020 - 01/2020
2	Colitis 01/2019 - 01/2019
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2019 - 08/2015
2	Ischemia 12/2018 - 12/2017

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2015
10	Pharmaceutical PreparationsIBA 10/2021 - 01/2017
7	Proteins (Proteins, Gene)FDA Link 08/2022 - 12/2019
6	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2014
5	EnzymesIBA 10/2021 - 06/2012
4	LipidsIBA 08/2022 - 05/2019
4	Interleukin-8 (Interleukin 8)IBA 02/2022 - 01/2019
4	abirateroneIBA 01/2022 - 11/2019
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 01/2018
4	Phosphotransferases (Kinase)IBA 01/2021 - 01/2017
4	CytokinesIBA 01/2021 - 03/2016
3	AnticoagulantsIBA 01/2022 - 01/2020
3	enzalutamideIBA 01/2022 - 11/2019
3	DNA (Deoxyribonucleic Acid)IBA 05/2021 - 01/2021
3	Bombesin Receptors (Bombesin Receptor)IBA 02/2021 - 01/2018
3	Hormones (Hormone)IBA 01/2021 - 08/2019
3	FructoseIBA 01/2021 - 09/2020
3	Interleukin-10 (Interleukin 10)IBA 01/2021 - 01/2019
3	Insulin (Novolin)FDA Link 01/2021 - 05/2013
3	Alanine Transaminase (SGPT)IBA 01/2019 - 01/2019
2	Biological ProductsIBA 01/2022 - 12/2021
2	Sincalide FDA Link 01/2022 - 01/2020
2	Neoplasm Antigens (Tumor Antigens)IBA 12/2021 - 12/2021
2	AntigensIBA 12/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 12/2021 - 03/2016
2	mRNA VaccinesIBA 12/2021 - 12/2021
2	NivolumabIBA 11/2021 - 01/2019
2	ImmunosorbentsIBA 10/2021 - 01/2019
2	Troponin T (Troponin T1)IBA 10/2021 - 01/2020
2	Miconazole (Monistat)FDA LinkGeneric 04/2021 - 07/2020
2	Metformin (Glucophage)FDA LinkGeneric 04/2021 - 01/2014
2	Urea (Carbamide)FDA LinkGeneric 04/2021 - 01/2019
2	AMP-Activated Protein KinasesIBA 04/2021 - 03/2016
2	Immune Checkpoint InhibitorsIBA 03/2021 - 01/2019
2	Therapeutic UsesIBA 03/2021 - 02/2021
2	BombesinIBA 02/2021 - 01/2018
2	Fluorescent Dyes (Fluorescent Probes)IBA 02/2021 - 01/2021
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 08/2015
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 01/2018
2	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 01/2021
2	Phosphofructokinase-2 (Phosphofructokinase 2)IBA 01/2021 - 06/2012
2	LDL CholesterolIBA 01/2020 - 04/2015
2	hydroxysafflor yellow AIBA 12/2019 - 12/2017
2	Ethanol (Ethyl Alcohol)IBA 07/2019 - 12/2017
2	IpilimumabIBA 01/2019 - 01/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2019 - 01/2019
2	Caspase 3 (Caspase-3)IBA 01/2019 - 02/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 01/2019
2	AntioxidantsIBA 12/2018 - 12/2017

Therapy/Procedure

19	Therapeutics 07/2022 - 01/2017
6	Immunotherapy 01/2022 - 01/2020
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2019
5	Castration 01/2022 - 11/2019
5	Nephroureterectomy 05/2019 - 10/2018
4	Radiotherapy 03/2021 - 01/2019
2	Prostatectomy (Retropubic Prostatectomy) 05/2022 - 08/2019
2	Lasers (Laser) 01/2022 - 12/2019
2	Photothermal Therapy 12/2021 - 01/2020
2	Photochemotherapy (Photodynamic Therapy) 02/2021 - 01/2021
2	Hepatectomy 04/2020 - 01/2019
2	Blood Transfusion (Blood Transfusions) 12/2019 - 01/2019